PROXY
STATEMENT
FOR
SPECIAL
MEETING OF STOCKHOLDERS
This
proxy statement is furnished in connection with the solicitation of proxies by our Board of Directors for use at the Special Meeting
of Stockholders of RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company,” “we,” “us”
or “our”), to be held on August 16, 2016 or at any adjournment or postponement thereof, at the time and place and
for the purposes specified in the accompanying notice of special meeting.
All
properly delivered proxies pursuant to this solicitation, and not later revoked, will be voted at the special meeting in accordance
with the instructions given in the proxy. When voting regarding the approval of the amendment to our second restated certificate
of incorporation (i) to effect, at the discretion of our Board of Directors, a three hundred twenty five-to-one (325 to 1) reverse
stock split of the outstanding shares of all of the outstanding shares of our common stock, par value $0.001 per share, and (ii)
to set the Company’s authorized shares of stock at 70,000,000 shares consisting of 65,000,000 shares designated as common
stock, par value $0.001 per share, and 5,000,000 shares designated as preferred stock, with stated value and other terms to be
determined at the discretion of the Board of Directors (the “Proposal”), stockholders may vote
for
or
against
the Proposal or may
abstain
from voting. Stockholders should vote their shares on the proxy card we have provided.
If no choice is indicated, proxies that are signed and returned will be voted
for
the Proposal.
All
shares of our common stock represented by properly delivered and unrevoked proxies will be voted if such proxies are received
in time for the meeting.
QUORUM,
VOTE REQUIRED AND REVOCATION OF PROXIES
The
Board of Directors has established July 5, 2016 as the record date for the determination of stockholders entitled to notice of
and to vote at the special meeting. As of the record date, 656,159,420 shares of common stock and 37,500 of Series B Convertible
Preferred Stock (“Series B Preferred”), which is non-voting, were outstanding. The Company previously had also issued
Series G 1.5% Convertible Preferred Stock. All shares of Series G 1.5% Convertible Preferred Stock that had not been earlier converted
were mandatorily redeemed by conversion according to the terms of the Series G into shares of the Company’s common stock
on April 17, 2016, resulting in no shares of Series G 1.5% Convertible Preferred Stock outstanding as of the record date. The
total of common stock mentioned above reflects the results of this conversion. Each share of common stock is entitled to one vote
upon the Proposal. Based on the ownership of common stock as of the record date with respect to the special meeting, holders of
the common stock are entitled to cast all of the votes entitled to be cast. The presence, in person or by proxy, of the holders
of shares of capital stock entitled to cast a majority of the votes that could be cast at the special meeting by the holders of
all outstanding shares of capital stock entitled to vote at the meeting is necessary to constitute a quorum.
The
Proposal is subject to the approval of the holders of a majority in voting power of the outstanding common stock entitled to vote
on the Proposal.
Brokers
holding shares of our common stock must vote according to specific instructions they receive from the beneficial owners of those
shares. If brokers do not receive specific instructions, they cannot vote on the Proposal. If you do not instruct your broker
how to vote on the Proposal, your broker will not vote on your behalf.
Abstentions
and broker non-votes are counted as present in determining whether the quorum requirement is satisfied. Because the Proposal requires
the approval of the holders of a majority in voting power of the outstanding common stock, abstentions and broker non-votes will
count as votes against the Proposal.
Any
holder of our capital stock has the right to revoke his or her proxy at any time prior to the voting thereof at the special meeting
by (1) filing a written revocation with the Secretary of the Company prior to the voting of such proxy, (2) giving a duly executed
proxy bearing a later date, or (3) attending the special meeting and voting in person. Attendance by a stockholder at the special
meeting will not itself revoke his or her proxy. If you hold your shares in the name of a bank, broker or other nominee, you should
follow the instructions provided by your bank, broker or nominee in revoking your previously granted proxy.
COST
AND METHOD OF PROXY SOLICITATION
The
Company will bear the cost of the solicitation of proxies. In addition to solicitation by mail, our directors, officers and employees
may solicit proxies from stockholders by telephone, facsimile or electronic mail (e-mail), or in person. We will supply banks,
brokers, dealers and other custodian nominees and fiduciaries with proxy materials to enable them to send a copy of such material
by mail to each beneficial owner of shares of our common stock that they hold of record and will, upon request, reimburse them
for their reasonable expenses in doing so.
APPROVAL
OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION
TO EFFECT REVERSE STOCK SPLIT AND REVISE THE NUMBER
OF AUTHORIZED SHARES
Amendment
to Our Second Restated Certificate of Incorporation to Effect the Reverse Stock Split and Reduce Our Authorized Shares
Our
Board of Directors has unanimously adopted a resolution declaring advisable, and recommending to our stockholders for their approval,
an amendment to Article Fourth of our second restated certificate of incorporation (i) authorizing a three hundred twenty five-to-one
(325 to 1) reverse stock split of the outstanding shares of our common stock (the “Reverse Stock Split”), (ii) restating
the number of authorized shares of the Company to be 70,000,000 shares consisting of 65,000,000 shares designated as common stock,
par value $0.001 per share, and 5,000,000 shares designated as preferred stock, with stated value and other terms to be determined
at the discretion of the Board of Directors, and (iii) granting the Board of Directors the discretion to file a certificate of
amendment to our second restated certificate of incorporation with the Secretary of State of the State of Delaware effecting the
Reverse Stock Split and restating the number of authorized shares or to abandon the Reverse Stock Split and the restatement of
the number of authorized shares altogether. The form of the proposed amendment is attached to this proxy statement as
Annex
A
(the “Proposed Amendment”). The Proposed Amendment will effect the Reverse Stock Split by reducing the number
of outstanding shares of common stock to approximately one-three hundred and twenty fifth of the number of outstanding shares
immediately prior to the effectiveness of the Reverse Stock Split, but will not increase the par value of common stock, and will
change the number of authorized shares of our capital stock to be 70,000,000 shares consisting of 65,000,000 shares designated
as common stock, par value $0.001 per share, and 5,000,000 shares designated as preferred stock, with stated value and other terms
to be determined at the discretion of the Board of Directors. If implemented, the number of shares of our common stock owned by
each of our stockholders will be reduced by the same proportion as the reduction in the total number of shares of our common stock
outstanding, so that the percentage of our outstanding common stock owned by each of our stockholders will remain approximately
the same, except to the extent that the Reverse Stock Split could result in some or all of our stockholders receiving cash in
lieu of any fractional shares.
Reasons
for the Proposed Amendment
On
the date of the mailing of this proxy statement, our common stock was quoted on the OTCQB under the symbol “RSPI”.
Our
Board of Directors has determined that the listing of our common stock on Nasdaq Capital Market or the NYSE MKT (formerly the
American Stock Exchange) or some other national stock exchange in the United States (a “National Exchange”) would
be beneficial for our stockholders. The initial listing requirements of the Nasdaq Capital Market, for example, provide, among
other things, that our common stock must maintain a closing bid price in excess of $3.00 per share under certain circumstances.
Continued listing requirements are somewhat less stringent. Our common stock has not maintained a bid price in excess of $3.00
per share since October 2006. If our common stock is listed on a National Exchange, the Board of Directors believes that the trading
market for our common stock could become significantly more liquid, which could further increase the trading price of our common
stock and decrease the transaction costs of trading in shares of our common stock. However, there can be no assurance that this
will occur.
The
purpose of the Reverse Stock Split is to decrease the total number of shares of our common stock outstanding and increase the
market price of our common stock. The Board of Directors intends to effect the Reverse Stock Split only if it believes that a
decrease in the number of shares outstanding is in the best interests of the Company and our stockholders, and is likely to improve
the trading price of our common stock and improve the likelihood that we will be able to list the Company on a National Exchange.
There are other requirements to list on any National Exchange and the Reverse Split will not, in itself, permit us to list on
such market or even guarantee that our stock price will increase and remain high enough to meet such requirement.
In
addition, if the number of the Company’s outstanding common shares is reduced dramatically as proposed by the Reverse Stock
Split, the Company would no longer need the number of authorized shares currently provided in its charter. Moreover, the state
franchise tax of the Company may be reduced by reducing the number of authorized shares. However, the Board of Directors has determined
that reducing the number of authorized shares by the same ratio as the number of outstanding shares will be reduced by the Proposed
Amendment would not permit the Company sufficient shares to support the issuance of equity capital by the Company in the future.
Historically, the Company has issued shares to settle debt, in connection with acquisitions, to pay compensation to its officers,
directors, consultants and advisors, and to secure additional capital. The Company may use its additional equity for any or all
of these purposes, or other purposes, in the future. Accordingly, the Board of Directors has approved the reduction of authorized
shares as set forth in the Proposed Amendment, which balances these two concerns, reducing the number of authorized shares substantially,
while retaining a sufficient number of shares for the use by Company for those purposes described above.
If
the Proposed Amendment is approved by our stockholders, the Board of Directors will have the discretion to implement the Proposed
Amendment or to not effect the Proposed Amendment at all. The Board of Directors currently intends to effect the Proposed Amendment
unless it determines that doing so would not have the desired effect of supporting the listing of our common stock on a National
Exchange. Following the Proposed Amendment, if implemented, there can be no assurance that the market price of our common stock
will rise in proportion to the reduction in the number of outstanding shares resulting from the Reverse Stock Split, or that we
can maintain such price if obtained. It is also possible that other factors will prevent the listing of our common stock on a
National Exchange.
The
market price of our common stock is dependent upon our performance and other factors, some of which are unrelated to the number
of shares outstanding. If the Reverse Stock Split is effected and the market price of our common stock declines, the percentage
decline as an absolute number and as a percentage of our overall market capitalization may be substantially greater than would
occur in the absence of the Reverse Stock Split. Furthermore, the reduced number of shares that will be outstanding after the
Reverse Stock Split could significantly reduce the trading volume and otherwise adversely affect the trading market in and the
liquidity of our common stock.
If
our stockholders approve the Proposed Amendment at the special meeting, the Reverse Stock Split will be effected, if at all, only
upon a determination by the Board of Directors that the Reverse Stock Split is in the best interests of the Company and its stockholders
at that time. No further action on the part of the stockholders will be required to either effect or abandon the Reverse Stock
Split. An appropriate announcement and/or a filing with the Securities and Exchange Commission will be made if and when the Board
of Directors determines to effect the Reverse Stock Split. The Company will also be required to advise FINRA OTC Corporate Actions
of such corporate action.
We
have not proposed the Reverse Stock Split in response to any effort of which we are aware to accumulate our shares of common stock
or to facilitate any party obtaining control of the Company, nor is it a plan by management to recommend a series of similar actions
to our Board of Directors or our stockholders. Notwithstanding the decrease in the number of outstanding shares of common stock
following the Proposed Amendment, our Board of Directors does not intend for this transaction to be the first step in a “going
private transaction” within the meaning of Rule 13e-3 of the Securities Exchange Act of 1934 (the “Exchange Act”).
In addition, we have not proposed the Proposed Amendment, with its decrease, but not proportional decrease, in the authorized
and unissued number of shares of common stock, with the intention of using the additional shares for anti-takeover purposes, although
we could theoretically use the additional shares to make more difficult or to discourage an attempt to acquire control of the
Company. The primary purpose of the Reverse Stock Split is to facilitate the Company’s listing on a National Exchange, which
management and the Board of Directors believe will increase the Company’s ability to raise additional equity capital to
fund its operations and, in particular, its research and development programs, including its ongoing and planned clinical trials.
We
do not believe that our officers or directors have interests in this proposal that are different from or greater than those of
any other of our stockholders, other than permitting there to be as sufficient number of outstanding shares to continue to compensate
our officers and directors in part with equity, as we have done in the past. Recently, the Company has put in place management
contracts that provide for cash payments of compensation for our officers in the future, and the Company expects to continue to
move toward a balance of cash and equity compensation. Other than due to the immaterial effects of the Company paying cash in
lieu of issuing fractional shares, we believe that the percentage ownership by management will not change materially after effecting
the Reverse Stock Split.
Effects
of the Reverse Stock Split on Common Stock
Pursuant
to the Reverse Stock Split, each holder of our common stock outstanding immediately prior to the effectiveness of the Proposed
Amendment (“Old Common Stock”) will become the holder of fewer shares of our common stock (“New Common Stock”)
after consummation of the Reverse Stock Split.
Although
the Reverse Stock Split will not, by itself, impact our assets, operations or prospects, the Reverse Stock Split could result
in a decrease in the aggregate market value of our common stock. The Board of Directors believes that this risk is outweighed
by the benefits of a potential listing of our common stock on a National Exchange.
If
effected, the Reverse Stock Split will result in some stockholders owning “odd-lots” of less than 100 shares of common
stock. Brokerage commissions and other costs of transactions in odd-lots are generally higher than the costs of transactions in
“round-lots” of even multiples of 100 shares.
Based
on 656,159,420 shares of our common stock outstanding as of the record date, the following table reflects an estimate of the approximate
number of shares of our common stock that would be outstanding as a result of the Reverse Stock Split.
Approximate
Number of Shares of
Common Stock Outstanding
before the Reverse Stock Split
|
|
Proposed
Ratio
|
|
Approximate
Number of Shares of
Common Stock to be Outstanding
after the Reverse Stock Split
|
656,159,420*
|
|
325:1
(Old Common Stock:
New Common Stock)
|
|
2,018,952
*
|
*
A small portion of the shares of common stock outstanding prior to the Reverse Stock Split shown above will be cashed out in
the Reverse Stock Split as fractional shares, as discussed elsewhere in this proxy statement. The exact number of shares will
be calculated as of the effective date of the Proposed Amendment. As a result, the final number of shares outstanding after
the Reverse Stock Split is expected to be slightly less than the number shown above.
The
Reverse Stock Split will affect all stockholders equally and will not affect any stockholder’s proportionate equity interest
in the Company, except with respect to those stockholders whose fractional shares will be mandatorily repurchased by the Company.
None of the rights currently accruing to holders of our common stock will be affected by the Reverse Stock Split. Following the
Reverse Stock Split, each share of New Common Stock will entitle the holder thereof to one vote per share and will otherwise be
identical to Old Common Stock. The Reverse Stock Split, in itself, also will have no effect on the number of authorized shares
of our common stock, but the Proposed Amendment will also adjust the number of authorized shares as set forth in the Proposed
Amendment. The shares of New Common Stock will be fully paid and non-assessable.
We
are currently authorized to issue a maximum of 1,400,000,000 shares of our common stock. As of the record date, there were 656,159,420
shares of our common stock issued and outstanding. The number of authorized shares of our common stock will change as a result
of the Proposed Amendment, and the number of shares of our common stock issued and outstanding will be reduced substantially and
at a higher ratio than the reduction of our authorized shares. As a result, the Proposed Amendment will effectively increase the
number of authorized and unissued shares of our common stock available for future issuance. With respect to the number of shares
reserved for issuance under our 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan (the “2014 Plan”)
and our 2015 Stock and Stock Option Plan (the “2015 Plan” and together with the 2014 Plan, the “Equity Plans”),
our Board of Directors will proportionately reduce such reserve in accordance with the terms of the Plans. As of May 31, 2016,
there were 40,633,002 shares of common stock reserved for issuance under the 2014 Plan, of which 20,551,702 remained available
for future awards and 490,935,714 shares of common stock reserved for issuance under the 2015 Plan, of which 103,507,142 remained
available for future awards. Following the Reverse Stock Split, if any, such reserve will be reduced to 125,024 shares of common
stock, of which 63,236 will be available for future awards under the 2014 Plan, and 1,510,572 shares of common stock, of which
318,483 will be available for future awards under the 2015 Plan.
Following
the Reverse Stock Split, the Board of Directors will have the authority, subject to applicable securities laws, to issue all authorized
and unissued shares without further stockholder approval, upon such terms and conditions as the Board of Directors deems appropriate.
We do not currently have any definitive or binding plans, proposals or understandings to issue the additional shares that would
be available if the Reverse Stock Split is approved and effected. However, the Company continues to need capital to finance its
future operations and business activities. We continue to consider and explore opportunities, and are in various stages of discussions
with respect to potential transactions to raise new capital. The Company believes that it is likely that it will issue equity
in the near future to obtain necessary capital. Additional financings based on debt, equity, some combination of debt and equity,
or otherwise are likely in the future.
Effects
of the Reverse Stock Split on Outstanding Stock Options and Warrants to Purchase Common Stock
If
the Reverse Stock Split is effected, all outstanding stock options and warrants entitling their holders to purchase shares of
our common stock will be proportionately reduced by our Board of Directors and/or by their terms in the same ratio as the reduction
in the number of shares of outstanding common stock, except that any fractional shares resulting from such reduction will be rounded
down to the nearest whole share to comply with the requirements of the Internal Revenue Code of 1986, as amended (the “Code”),
Section 409A. Correspondingly, the per share exercise price of such stock options will be increased in direct proportion to the
Reverse Stock Split ratio, so that the aggregate dollar amount payable for the purchase of the shares subject to the stock options
and warrants will remain unchanged. For example, assuming that we effect the Reverse Stock Split and that an optionee holds stock
options to purchase 975 shares of our common stock at an exercise price of $1.00 per share, upon the effectiveness of the Reverse
Stock Split, the number of shares of the common stock subject to that option would be reduced to 3 and the exercise price would
be proportionately increased to $325.00 per share. Holders of outstanding stock options and warrants to purchase shares of common
stock do not have any rights of common stockholders, including voting rights, until such stock options or warrants are exercised
and the underlying common shares are issued. Stock options and warrants to purchase shares of common stock do not have the right
to receive cash under any circumstances.
Effects
of the Reverse Stock Split on Preferred Stock
The
Proposed Amendment will not change the number of authorized shares of Series B Preferred. As provided in the Certificate of Designation
of our Series B Convertible Preferred Stock, included as Exhibit B in our second restated certificate of incorporation, the conversion
rate of the Series B Preferred will automatically be adjusted to reflect the Reverse Stock Split.
Accounting
Matters
The
par value per share of the common stock will remain unchanged at $0.001 per share after the Reverse Stock Split. As a result,
on the effective date of the Reverse Stock Split, if any, the stated capital on our balance sheet attributable to the common stock
will be reduced proportionately based on the three hundred twenty five-to-one (325 to 1) Reverse Stock Split ratio, from its present
amount, and the additional paid-in capital account will be credited with the amount by which the stated capital is reduced. After
the Reverse Stock Split, net income or loss per share and other per share amounts will be increased because there will be fewer
shares of our common stock outstanding. In addition, other than as a result of paying cash in lieu of issuing fractional shares,
the Reverse Stock Split will not impact the total amount of stockholder’s equity on the Company’s balance sheet. In
future financial statements, net income or loss per share and other per share amounts for all periods ending before the Reverse
Stock Split will be restated to give retroactive effect to the impact of the Reverse Stock Split.
As
described above under “Effects of the Reverse Stock Split on Outstanding Stock Options and Warrants to Purchase Common Stock,”
the per share exercise price of outstanding stock option awards and warrants would increase proportionately, and the number of
shares of our common stock issuable upon the exercise of outstanding stock options and warrants would decrease proportionately,
in each case based on the three hundred twenty five-to-one (325 to 1) Reverse Stock Split ratio. The Company does not anticipate
that the Reverse Stock Split will have a material affect (other than those described above) on the Company’s results of
operation, from a cash, revenue, expense or profitability perspective, or that any other accounting consequences would arise as
a result of the Reverse Stock Split.
Shares
of Common Stock Issued and Outstanding
With
the exception of the number of shares issued and outstanding, the rights and preferences of the shares of our common stock prior
and subsequent to the Reverse Stock Split will remain the same. After the effectiveness of the Reverse Stock Split, we do not
anticipate that our financial condition, the percentage ownership of management, or any aspect of our business or operations would
materially change as a result of the Reverse Stock Split.
Any of our stockholders holding less than 325 shares of common
stock will cease be a stockholder of the Company as a result of the payment of cash in lieu of issuing fractional shares.
Our
common stock is currently registered under Section 12(b) of the Exchange Act, and as a result, we are subject to the periodic
reporting and other requirements of the Exchange Act. If effected, the proposed Reverse Stock Split will not affect the registration
of our common stock under the Exchange Act or our periodic or other reporting requirements thereunder.
Increase
of Shares of Common Stock Available for Future Issuance
As
a result of the Proposed Amendment, there will be a reduction in the number of shares of our common stock issued and outstanding,
and a decrease, though not proportionate, in the number of authorized shares that would be unissued and available for future issuance
after the Proposed Amendment is effected. Such shares could be used for any proper corporate purpose approved by the Board of
Directors including, among other purposes, future financing transactions.
Holders
of our common stock have no preemptive or other subscription rights.
Effectiveness
of the Proposed Amendment
The
Proposed Amendment, if approved by our stockholders, will become effective upon the filing with the Secretary of State of the
State of Delaware of a certificate of amendment to our second restated certificate of incorporation, as amended, in substantially
the form of the Proposed Amendment attached to this proxy statement as
Annex A
. The exact timing of the filing of the Proposed
Amendment will be determined by the Board of Directors based upon its evaluation of when such action will be most advantageous
to the Company and our stockholders. The Board of Directors reserves the right, notwithstanding stockholder approval and without
further action by our stockholders, to elect not to proceed with the Proposed Amendment if, at any time prior to filing such Proposed
Amendment, the Board of Directors, in its sole discretion, determines that it is no longer in the best interests of the Company
and our stockholders. The Board of Directors currently intends to effect the Proposed Amendment unless it determines that doing
so would not have the desired effect of supporting the listing of our common stock on a National Exchange.
Assuming
the Proposed Amendment is approved by the stockholders, the Board of Directors intends to effect the amendment, or abandon it,
within sixty days of the date of the Special Meeting.
Effect
on Registered and Beneficial Stockholders
Upon
the effectiveness of the Reverse Stock Split, the Company intends to treat stockholders holding shares of our common stock in
“street name” (that is, held through a bank, broker or other nominee) in the same manner as stockholders of record
whose shares of common stock are registered in their names. Banks, brokers or other nominees will be instructed to effect the
Reverse Stock Split for their beneficial holders holding shares of our common stock in “street name;” however,
these banks, brokers or other nominees may apply their own specific procedures for processing the Reverse Stock Split. If you
hold your shares of our common stock with a bank, broker or other nominee, and have any questions in this regard, the Company
encourages you to contact your nominee directly.
Effect
on “Book-Entry” Stockholders of Record
The
Company’s stockholders of record may hold some or all of their shares electronically in book-entry form. These stockholders
will not have stock certificates evidencing their ownership of our common stock; however, they are provided with a statement reflecting
the number of shares of common stock registered in their accounts.
If
you hold registered shares of Old Common Stock in a book-entry form, you do not need to take any action to receive your shares
of New Common Stock in registered book-entry form, if applicable. A transaction statement will automatically be sent to your address
of record as soon as practicable after the effective time of the Reverse Stock Split indicating the number of shares of New Common
Stock you hold, and, if applicable, payment with respect to any fractional shares will be deposited directly into your account
with the organization holding your shares.
Effect
on Registered Certificated Shares
Some
stockholders of record hold their shares of our common stock in certificate form or a combination of certificate and book-entry
form. If any of your shares of our common stock are held in certificate form, you will be sent a transmittal letter by the Company
or the Company’s transfer agent as soon as practicable after the effective time of the Reverse Stock Split, if any. The
transmittal letter will be accompanied by instructions specifying how to exchange your certificate representing the Old Common
Stock for a statement of holding or a certificate of New Common Stock and, if applicable, payment with respect to any fractional
shares, which will be made by check.
STOCKHOLDERS
SHOULD NOT DESTROY ANY SHARE CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL ADVISED TO DO SO.
Fractional
Shares
Fractional
shares will not be issued in connection with the Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split
will not be issued but will be paid out in cash (without interest or deduction) in an amount equal to the number of shares exchanged
into such fractional share multiplied by the average closing trading price of our common stock on the OTCQB for the five trading
days immediately before the certificate of amendment effecting the Reverse Share Split is filed with the Delaware Secretary of
State.
If
a stockholder who holds shares in certificated form is entitled to a payment in lieu of any fractional share interest, the stockholder
will receive a check as soon as practicable after the effective time and after the stockholder has submitted an executed letter
of transmittal and surrendered all stock certificates, as described above in “Effect on Registered Certificated Shares.”
Stockholders who hold shares of common stock with a broker, bank or other nominee should contact their broker, bank or other nominee
for information on the treatment and processing of fractional shares. By signing and cashing the check, stockholders will warrant
that they owned the shares of common stock for which they received a cash payment. The cash payment is subject to applicable federal
and state income tax and state abandoned property laws. Stockholders will not be entitled to receive interest for the period of
time between the effective time and the date payment is received.
As
a result of the Reverse Stock Split, holders of less than 325 shares of common stock would be eliminated as stockholders of the
Company as a result of the payment of cash in lieu of issuing fractional shares.
Appraisal
Rights
Under
the Delaware General Corporation Law, our stockholders are not entitled to appraisal or dissenter’s rights with respect
to the Proposed Amendment, and we will not independently provide our stockholders with any such rights.
Certain
Federal Income Tax Consequences
The
following is a discussion of certain material U.S. federal income tax consequences of the Reverse Stock Split to U.S. holders
(as defined below). This discussion is included for general information purposes only and does not purport to address all aspects
of U.S. federal income tax law that may be relevant to U.S. holders in light of their particular circumstances. This discussion
is based on the Code and current Treasury regulations, administrative rulings and court decisions, all of which are subject to
change, possibly on a retroactive basis, and any such change could affect the continuing validity of this discussion.
STOCKHOLDERS
ARE URGED TO CONSULT THEIR TAX ADVISORS AS TO THE PARTICULAR FEDERAL, STATE, LOCAL, OR FOREIGN TAX CONSEQUENCES TO THEM OF THE
REVERSE STOCK SPLIT.
This
discussion does not address tax consequences to stockholders that are subject to special tax rules, such as banks, insurance companies,
regulated investment companies, personal holding companies, U.S. holders whose functional currency is not the U.S. dollar, partnerships
(or other flow-through entities for U.S. federal income purposes and their partners or members), persons who acquired their shares
in connection with employment or other performance of services, broker-dealers, foreign entities, nonresident alien individuals
and tax-exempt entities. This summary also assumes that the Old Common Stock shares were, and the New Common stock shares will
be, held as a “capital asset,” as defined in Section 1221 of the Code.
As
used herein, the term “U.S. holder” means a holder that is, for U.S. federal income tax purposes:
|
●
|
an
individual citizen or resident of the United States;
|
|
|
|
|
●
|
a
corporation or other entity taxed as a corporation created or organized in or under the laws of the United States or any political
subdivision thereof;
|
|
|
|
|
●
|
an
estate the income of which is subject to U.S. federal income tax regardless of its source; or
|
|
|
|
|
●
|
a
trust (A) if a U.S. court is able to exercise primary supervision over the administration of the trust and one or more “U.S.
persons” (as defined in the Code) have the authority to control all substantial decisions of the trust or (B) that has
a valid election in effect to be treated as a U.S. person.
|
Other
than with respect to any stockholder that receives cash in lieu of any fractional share, a stockholder generally will not recognize
a gain or loss by reason of such stockholder’s receipt of shares of New Common Stock pursuant to the Reverse Stock Split
solely in exchange for shares of Old Common Stock held by such stockholder immediately prior to the Reverse Stock Split. A stockholder’s
aggregate tax basis in the shares of New Common Stock received pursuant to the Reverse Stock Split (including any fractional shares)
will equal the stockholder’s aggregate basis in the Old Common Stock exchanged therefore and will be allocated among the
shares of New Common Stock received in the Reverse Stock Split on a pro-rata basis. Stockholders who have used the specific identification
method to identify their basis in the shares of Old Common Stock held immediately prior to the Reverse Stock Split should consult
their own tax advisers to determine their basis in the shares of New Common Stock received in exchange therefor in the Reverse
Stock Split. A stockholder’s holding period in the shares of New Common Stock received pursuant to the Reverse Stock Split
will include the stockholder’s holding period in the shares of Old Common Stock surrendered in exchange therefore, provided
the shares of Old Common Stock surrendered are held as capital assets at the time of the Reverse Stock Split.
No
gain or loss will be recognized by us for accounting or tax purposes as a result of the Reverse Stock Split.
This
section does not address, and the Company makes no representations regarding, any state, local or foreign tax law consequences.
As mentioned above, you are urged to consult your tax advisor regarding these potential tax consequences.
Vote
Required and Board Recommendation
Approval
of the foregoing proposal requires the affirmative vote of the holders of a majority in voting power of the common stock. Your
board of directors recommends a vote “
FOR
” approval of the amendment of the second restated certificate of
incorporation to effect the Proposed Amendment.